Table 1 Characteristics of patients during the hospitalization for Covid-19
From: Residual respiratory impairment after COVID-19 pneumonia
Available observations | N = 87 | |
|---|---|---|
Age, years | 58 (13) | |
Male, n (%) | 58 (67) | |
BMI (kg/m2) | 26.7 (4.4) | |
p/F worst | 76 | 281 (150)* |
Hospitalization time (days) | 86 | 13 (10)* |
Day from discharge (days) | 85 | 35 (21)* |
Smoking history, n (%) | 85 | |
Never smoker | 33 (39) | |
Smoker | 4 (5) | |
Former smoker | 48 (56) | |
Pulmonary disease history, n (%) | 86 | |
COPD | 3 (4) | |
Asthma | 9 (11) | |
Radiology (chest XR or CT), n (%) | 86 | |
Chest CT performed | 51 (59) | |
Unilateral involvement | 16 (19) | |
Bilateral involvement | 70 (81) | |
Antiviral therapy, n (%) | 86 | |
Lopinavir/Ritonavir | 37 (43) | |
Darunavir/Ritonavir | 53 (62) | |
Anti-IL-6, n (%) | 86 | 31 (36) |
Enoxaparin, n (%) | 86 | 42 (49) |
Azithromycin, n (%) | 86 | 41 (48) |
Hydroxychloroquine, n (%) | 86 | 81 (94) |
Corticosteroids, n (%) | 86 | 6 (7) |
Respiratory support, n (%) | 86 | |
Ventimask | 56 (65) | |
HFNC | 9 (11) | |
NIV or CPAP | 13 (15) | |
Orotracheal Intubation | 6 (7) | |
ICU admission, n (%) | 86 | 15 (17) |
FVC | 83 | |
Litres | 3.9 (1.1) | |
% predicted | 104.6 (18.5) | |
FEV-1 | 83 | |
Litres | 3.1 (0.9) | |
% predicted | 102.8 (16.0) | |
FEV-1/FVC | 83 | |
% predicted | 79.6 (5.8) | |
TLC | 82 | |
Litres | 5.7 (1.3) | |
% predicted | 89.6 (14.6) | |
DLco | 83 | |
Litres | 21.2 (6.8) | |
% predicted | 77.2 (16.5) | |
RV | 82 | |
Litres | 1.58 (0.47)* | |
% predicted | 74.8 (18.1) | |
RC/TLC | 82 | |
Ratio | 30 (10)* | |
% predicted | 79.0 (13.0) | |
ABG | 84 | |
pO2 (mmHg) | 91.4 (8.0) | |
pCO2 (mmHg) | 38.8 (3.1) | |
pH | 7.42 (0.02)* | |
d(A-a) (mmHg) | 13.0 (7.5) | |
6MWT | 82 | |
SpO2 basal | 97 (2)* | |
SpO2 nadir | 95 (4)* | |
Meters | 500 (88)* |